- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 21.10. | Despite US policy changes, drug prices stay stubbornly high | ||
| 21.10. | ViiV's Waterhouse exits to take the CEO job at CSL | ||
| 21.10. | CagriSema helps women lose 25% of their weight in study | ||
| 21.10. | GSK wins FDA green light for chronic hep B treatment Hibsago | ||
| 21.10. | UEGW delegates hear of strides forward in IBD treatment | ||
| 20.10. | Compounded tirzepatide recalled after FDA warning | ||
| 20.10. | Jemperli label extended to include rectal cancer | ||
| 20.10. | AI tool uses face photos to predict cancer survival | ||
| 20.10. | AZ and Oracle team up on AI platform for clinical trials | ||
| 20.10. | Roche offers $15bn for strategic-level deal with Hansoh | ||
| 20.10. | Merck KGaA buys Silence and its siRNA pipeline for $1.3bn | ||
| 19.10. | Novavax critic Shah Capital ends its activism campaign | ||
| 19.10. | UK Biobank partners industry on 'most detailed' immune map | ||
| 19.10. | Data reveal is promising for GSK's lung cancer drug ris-rez | ||
| 19.10. | Cancer biotech Nouscom adds €120m, and other financings | ||
| 16.10. | RNAi biotech City hauls in $200m in upsized IPO | ||
| 16.10. | CHMP backs Lilly's oral GLP-1 Foundayo for EU approval | ||
| 16.10. | FDA clears Roche's Enspryng for thyroid eye disease | ||
| 16.10. | RevMed nears EU okay for pancreatic cancer drug Rasonque | ||
| 16.10. | AI in drug discovery & development: News watch, October 2026 | ||
| 15.10. | ImmunityBio bags elusive label extension for Anktiva | ||
| 15.10. | GLP-1 drugs linked to reduced acute schizophrenia episodes | ||
| 15.10. | Roche breast cancer drug Itovebi turned down by NICE | ||
| 15.10. | Could OMass become the UK's 'big biotech' company? | ||
| 14.10. | GSK planning 1,200 job cuts in Belgium, says paper |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.